Synlogic, Inc. financial data

Symbol
SYBX on Nasdaq
Industry
Pharmaceutical Preparations
Location
Po Box 30, Winchester, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
Mirna Therapeutics, Inc. (to 8/25/2017)
Latest financial report
Mar 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 255 % -25%
Return On Equity -193 % -57.3%
Return On Assets -95.1 % -22%
Operating Margin -512K % -31182%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 11.7M shares +0.59%
Common Stock, Shares, Outstanding 11.7M shares +27.3%
Entity Public Float 4.1M USD -82.6%
Common Stock, Value, Issued 12K USD +20%
Weighted Average Number of Shares Outstanding, Basic 12.2M shares +87.6%
Weighted Average Number of Shares Outstanding, Diluted 12.2M shares +87.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 8K USD -99.8%
Research and Development Expense 29.6M USD -43.5%
General and Administrative Expense 6.63M USD -54.5%
Operating Income (Loss) -41M USD +25.8%
Nonoperating Income (Expense) 17.6M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -117K USD +99%
Income Tax Expense (Benefit) 0 USD -100%
Net Income (Loss) Attributable to Parent -23.4M USD +61.9%
Earnings Per Share, Basic -1.92 USD/shares +79.6%
Earnings Per Share, Diluted -1.92 USD/shares +79.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 18.9M USD -21.3%
Cash, Cash Equivalents, and Short-term Investments 18.9M USD
Other Assets, Current 75K USD -48.6%
Assets, Current 19.8M USD -60.4%
Property, Plant and Equipment, Net 0 USD -100%
Operating Lease, Right-of-Use Asset 0 USD -100%
Other Assets, Noncurrent 0 USD -100%
Assets 19.8M USD -73.8%
Accounts Payable, Current 164K USD -88.7%
Employee-related Liabilities, Current 126K USD -95.1%
Accrued Liabilities, Current 2.04M USD -32.1%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 7.08M USD -76.6%
Operating Lease, Liability, Noncurrent 0 USD -100%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD -100%
Retained Earnings (Accumulated Deficit) -442M USD -5.58%
Stockholders' Equity Attributable to Parent 12.8M USD -61.1%
Liabilities and Equity 19.8M USD -73.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -15.4M USD +28.2%
Net Cash Provided by (Used in) Financing Activities 16K USD -98.2%
Net Cash Provided by (Used in) Investing Activities 16.3M USD -46.2%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 12M shares +26.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 862K USD -91.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 134M USD +7.5%
Deferred Tax Assets, Gross 134M USD +4.73%
Operating Lease, Liability 17.3M USD -14.8%
Depreciation 347K USD -39.8%
Payments to Acquire Property, Plant, and Equipment 395K USD +176%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -23.4M USD +61.8%
Lessee, Operating Lease, Liability, to be Paid 20.4M USD -17.8%
Property, Plant and Equipment, Gross 19.9M USD -2.82%
Operating Lease, Liability, Current 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.79M USD -20.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.98M USD +6.24%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.09M USD -31%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.91M USD +2.98%
Deferred Tax Assets, Operating Loss Carryforwards 102M USD +16.9%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.02M USD +3%
Share-based Payment Arrangement, Expense 3.17M USD +12.9%
Interest Expense 0 USD -100%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares